Respiralimab (Respimax)
Product detail for Respiralimab, INN: respiralimab. Therapeutic area: Respiratory. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-012
INN
respiralimab
Therapeutic Area
Respiratory
Status
Pending
Owner
Priya Sharma
Created
2022-07-27
Last Updated
2024-04-10
Markets
8
Presentations
| Form | Strength | Route |
|---|---|---|
| Ophthalmic solution | 10 mg/mL | Inhalation |
| Inhalation powder | 100 mg | Intramuscular |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-034 | Mannitol | mannitol | 33013-15-7 | combination | Pending |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| HSA-2023-0012 | Italy | sNDA | In Progress | Priya Sharma | 2023-01-28 |
| EMA-2023-0042 | Italy | NDS | Blocked | Priya Sharma | 2024-02-09 |
| HSA-2023-0072 | Italy | MAA | Failed | Carlos Mendez | 2024-06-04 |
Markets (8)